These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24909)

  • 1. The importance of non-HLA systems and the feasibility of the use of unrelated donors in bone marrow transplantation.
    van Rood JJ; van Leeuwen A; Goulmy E; Termijtelen A; Bradley BA; Brand A; Eernisse JG
    Transplant Proc; 1978 Mar; 10(1):47-51. PubMed ID: 24909
    [No Abstract]   [Full Text] [Related]  

  • 2. Selection of related and unrelated bone marrow donors.
    Goldmann SF
    Transplant Proc; 1977 Mar; 9(1):507-11. PubMed ID: 17197
    [No Abstract]   [Full Text] [Related]  

  • 3. Major and minor histocompatibility systems in man and their importance in bone marrow transplantation.
    van Rood JJ; van Leeuwen A
    Transplant Proc; 1976 Sep; 8(3):429-36. PubMed ID: 62433
    [No Abstract]   [Full Text] [Related]  

  • 4. [The HLA complex. 3. Implications in transplantation and transfusion].
    Dausset J
    Nouv Presse Med; 1976 May; 5(22):1413-6. PubMed ID: 6945
    [No Abstract]   [Full Text] [Related]  

  • 5. Cellular immunogenetics of HLA: quantitative crossmatches for LD and CD determinants.
    Bach FH
    Transplant Proc; 1978 Mar; 10(1):63-6. PubMed ID: 76353
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tissue typing before bone marrow transplantation].
    Kosinski S
    Postepy Hig Med Dosw; 1979; 33(3):221-38. PubMed ID: 42045
    [No Abstract]   [Full Text] [Related]  

  • 7. Direct and antibody-dependent cell-mediated cytotoxicity against HLA identical sibling lymphocytes. Correlation with marrow graft rejections.
    Warren RP; Storb R; Weiden PL; Mickelson EM; Thomas ED
    Transplantation; 1976 Dec; 22(6):631-5. PubMed ID: 137561
    [No Abstract]   [Full Text] [Related]  

  • 8. Bone marrow transplanation for severe combined immunodeficiency with the HL-A-incompatible but MLC-identical mother as a donor.
    Neithammer D; Goldmann SF; Haas RJ; Dietrich M; Flad HD; Fliedner TM; Kleihauer E
    Transplant Proc; 1976 Dec; 8(4):623-8. PubMed ID: 11594
    [No Abstract]   [Full Text] [Related]  

  • 9. Histocompatibility and marrow transplantation.
    Hansen JA; Clift RA; Thomas ED; Buckner CD; Mickelson EM; Storb R
    Transplant Proc; 1979 Dec; 11(4):1924-9. PubMed ID: 43613
    [No Abstract]   [Full Text] [Related]  

  • 10. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of HLA and non-HLA antigens in bone marrow transplantation.
    Opelz G; Gale RP; Feig SA; Walker J; Terasaki PI; Saxon A
    Transplant Proc; 1978 Mar; 10(1):43-6. PubMed ID: 24908
    [No Abstract]   [Full Text] [Related]  

  • 12. Unrelated donors for bone-marrow transplantation and transfusion support: pool sizes required.
    Opelz G; Mickey MR; Terasaki PI
    Transplant Proc; 1974 Dec; 6(4):405-9. PubMed ID: 4280165
    [No Abstract]   [Full Text] [Related]  

  • 13. The problems and practice of bone marrow transplantation in man: the severe combined immunodeficiency syndrome as the ideal model.
    Levey RH
    Transplant Proc; 1972 Dec; 4(4):565-6. PubMed ID: 4405148
    [No Abstract]   [Full Text] [Related]  

  • 14. The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT).
    Bishara A; Amar A; Brautbar C; Condiotti R; Lazarovitz V; Nagler A
    Exp Hematol; 1995 Dec; 23(14):1667-75. PubMed ID: 8542963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marrow grafts between canine littermates showing one-way nonstimulation in mixed leukocyte culture.
    Storb R; Weiden PL; Schroeder ML; Graham TC
    Transplant Proc; 1975 Dec; 7(4):459-60. PubMed ID: 824
    [No Abstract]   [Full Text] [Related]  

  • 16. [Host-graft interactions after allogenic bone marrow transplantation; choice of donor].
    Alby N; Bernard A; Devergie A; Goldman JM; Hervé P; Maraninchi P; Raffoux C; Gluckman E
    Nouv Rev Fr Hematol (1978); 1988; 30(1-2):55-64. PubMed ID: 3290840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the mixed lymphocyte culture reaction in predicting acute graft-versus-host disease after marrow transplants from haploidentical and unrelated donors.
    Mickelson EM; Anasetti C; Yoon Choo S; Longton GM; Petersdorf EW; Martin PJ; Hansen JA
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1239-40. PubMed ID: 8442101
    [No Abstract]   [Full Text] [Related]  

  • 18. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of engraftment and graft-versus-host disease after canine marrow transplantation. Two phenomena linked to but not exclusively determined by known antigens of the major histocompatibility complex.
    Storb R; Weiden PL; Graham TC; Thomas ED
    Transplant Proc; 1978 Mar; 10(1):113-8. PubMed ID: 24904
    [No Abstract]   [Full Text] [Related]  

  • 20. The new serology of histocompatibility testing and its significance in human renal transplantation.
    Braun WE
    Urol Clin North Am; 1976 Oct; 3(3):503-25. PubMed ID: 136083
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.